Hypertension in pregnancy: Pathophysiology & management strategies

Current Pharmaceutical Design

Volumn 13, Issue 25, 2007, Pages 2567-2579

  Karthikeyan, V J ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Eclampsia; Gestational hypertension; Hypertension; Pre eclampsia

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; LABETALOL; MAGNESIUM; MAGNESIUM SULFATE; METHYLDOPA; METOPROLOL; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENYTOIN; PLACEBO; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; ZINC;

ANTIHYPERTENSIVE ACTIVITY; BRADYCARDIA; CLINICAL TRIAL; CONTINUOUS INFUSION; CONVULSION; CYANIDE POISONING; DIET SUPPLEMENTATION; DIPLOPIA; DISEASE SEVERITY; DIZZINESS; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; ECLAMPSIA; ENDOTHELIAL DYSFUNCTION; FETUS MONITORING; FLUSHING; GENETIC PREDISPOSITION; HEART ARREST; HEART ARRHYTHMIA; HEART PALPITATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; HYPERTENSIVE CRISIS; HYPOGLYCEMIA; HYPOTENSION; INTRAUTERINE GROWTH RETARDATION; LABOR INHIBITION; LIFESTYLE MODIFICATION; LIPID METABOLISM; LIPID PEROXIDATION; LOADING DRUG DOSE; LOW BIRTH WEIGHT; LOW DRUG DOSE; LUPUS LIKE SYNDROME; MAGNESIUM BLOOD LEVEL; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MATERNAL TREATMENT; NAUSEA; NEONATAL RESPIRATORY DISTRESS SYNDROME; OXIDATIVE STRESS; PARALYSIS; PATHOPHYSIOLOGY; PERINATAL MORTALITY; PREDICTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEINURIA; RESPIRATORY DISTRESS; REVIEW; SEIZURE; SIDE EFFECT; SKIN TINGLING; SLURRED SPEECH; SODIUM RESTRICTION; SOLUTIO PLACENTAE; SOMNOLENCE; SYNCYTIOTROPHOBLAST; TACHYCARDIA; TENDON REFLEX; TERATOGENICITY; THROMBOCYTOPENIA; UTERINE BLOOD VESSEL; VOMITING;

DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 34548787896     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207781663019     Document Type: Review

References (40)

1. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG Technical Bulletin No.: 219. Washington, DC: The College 1996; 1-8.
2. Lindheimer MD. Hypertension in pregnancy. Hypertension 1993; 22: 127-37.
3. de Swiet M. Cardiovascular physiology in normal pregnancy. In: Rubin PC, Ed. Hypertension in pregnancy. Amsterdam: Elsevier Science 2000; 1-12. (Handbook of hypertension; volume 21).
4. Report of the National High Blood Pressure Education Program Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
5. Coppage KH, Sibai BM. Treatment of hypertensive complications in pregnancy. Curr Pharm Des 2005; 11: 749-57.
6. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ 2005; 330(7491): 565.
7. Sibai B, Dekker G, Kupfermine M. Pre-eclampsia. Lancet 2005; 365(9461): 785-99.
8. Broughton-Pipkin F, Rubin PC. Pre-eclampsia - the "disease of theories". Br Med Bull 1994; 50: 381-96.
9. Ward K. Pre-eclampsia: A polygenic, multifactorial disorder. In: Rubin PC, Ed. Hypertension in pregnancy. Amsterdam: Elsevier Science 2000; 46-56. (Handbook of hypertension; volume 21).
10. Brackley K, Kilby MD. Pathogenesis of Pre-eclampsia. In: Churchill D, Beevers DG, Eds. Hypertension in pregnancy. London: BMJ 1999; 82-95.
11. Dekker GA, VanGeijn HP. Hypertensive disease in pregnancy. Curr Opin Obstet Gynecol 1992; 4(1): 10-27.
12. Robson SC. Hypertension and renal disease in pregnancy. In: Edmonds DK Ed. Dewhurst's Textbook of Obstetrics and Gynaecology for Postgraduates. 6th edition. Oxford: Blackwell Science 1999; 166-85.
13. Khan F, Belch JJF, MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension 2005; 46: 1123-28.
14. Nadar SK, Karalis I, Al Yemeni E, Blann AD, Lip GY. Plasma markers of angiogenesis in pregnancy induced hypertension. Thromb Haemost 2005; 94(5): 1071-6.
15. Kupferminc MJ, Fait G, Many A, Lessing JB, Yair D, Bar-Am A, et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 2001; 20(1): 35-44.
16. Knight M, Duley L, Henderson-Smart DJ, King JF. Anti-platelet agents for preventing and treating pre-eclampsia. Cochrane Database Syst Rev 2000; (2): CD000492.
17. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997; 337(2): 69-76.
18. Frishmarr WH, Schlocker SJ, Awad K, Tejani N. Pathophysiology and medical management of systemic hypertension in pregnancy: Cardiol Rev 2005; 1-3(6): 274-84.
19. Abalos E, Duley L, Steyn DW, Honderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2001; (2): CD0002252.
20. Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during pregnancy: The effects of specific treatment on the growth and development of the childrdn. Lancet 1982; 1(8273): 647-9
21. Gunenc O, Cicek N, Gorkemli H, Celik C, Acar A, Akyurek C. The effect of methyldopa treatment on uterine, umbilical and fetal middle cerebral artery blood flows in preeclamptic patients. Arch Gynecol Obstet 2002; 266(3): 141-14.
22. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990; 301(6752): 587-9.
23. Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999; 12(6): 541-7.
24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289(19): 2560-72.
25. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345(8963): 1455-63.
26. Gifford RW Jr. Management of hypertensive crises. JAMA 1991; 266(6): 829-35.
27. Striano P, Striano S, Tortora F, De Robertis E, Palumbo D, Elefante A, et al. Clinical spectrum and critical care management of Posterior Reversible Encephalopathy Syndrome (PRES). Med Sci Monit 2005; 11(11): CR549-53.
28. Pizon AF, Wolfson AB. Postpartum focal neurologic deficits: Posterior leukoencephalopathy syndrome. J Emerg Med 2005; 29(2): 163-6.
29. Meese RB, Ram CV. Hypertensive cardiovascular emergencies. Compr Ther 1985; 11(10): 28-38.
30. Barton JR, Sibai BM. Acute life-threatening emergencies in preeclampsia - eclampsia. Clin Obstet Gynecol 1992; 35(2): 402-13.
31. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105(2): 402-10.
32. Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ 1994; 309(6966): 1395-400.
33. Mattar F, Sibai BM, Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000; 182(2): 307-12.
34. Katz VL, Farmer R, Kuller JA. Preeclampsia into eclampsia: Toward a new paradigm. Am J Obstet Gynecol 2000; 182(6): 1389-96.
35. Chames MC, Livingston JC, Ivester TS. Barton JR, Sibai BM. Late postpartum eclampsia: A preventable disease? Am J Obstet Gynecol 2002; 186(6):1174-7.
36. Lubarsky SL, Barton JR, Friedman SA, Nasreddine S, Ramadan MK, Sibai BM. Late postpartum eclampsia revisited. Obstet Gynecol 1994; 83(4): 502-5.
37. Sibai BM, Diagnosis and management of gestational hypertension and preeclampsia. Obstet Qynecol 2003; 102(1): 181-92.
38. Biondi C, Pavan B, Lunghi L, Fiorini S, Vesce F. The role and modulation of the oxidative balance in pregnancy. Curr Pharm. Des 205; 11(16): 2075-89.
39. Nadar SK, Tayebjee MH, Messerli F, Lip GY. Target organ damage in hypertension: Pathophysiology and implications for drug therapy. Curr Pharm Des 2006; 12(13): 1581-92.
40. Webster WS, Howe AM, Abela D, Oakes DJ. The relationship between cleft lip, maxillary hypoplasia, hypoxia and phenytoin. Curr Pharm Des 2006; 12(12): 1431-48.